Well if there isn't some price action soon to take into account the FDA de-risking, this company will be taken out sooner, rather than later. I was thinking competitors will wait for AXP to spend their own $$ marketing it and establishing the market presence before they take out, but this MC seems like a no brainer to lob an offer on the table.
I just can't help to think the announcement yesterday about the new 510k has confused the market on its approval status.
Well if there isn't some price action soon to take into account...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 29583410 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59394450 | 39 |
View Market Depth
| Last trade - 16.13pm 20/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable